In summary, IgM expression can distinguish between t(8;14) BL that originate before CSR in the GC (IgMpos) and those that originate later in B cell development, after CSR (IgMneg); or instances where the t(8;14) tumor cells were nevertheless competent to complete CSR. The gene discussed is CD40LG; the disease is neoplasm.